RxDoctor Payments Data

Frederick Goll, MD

Otolaryngology · Henderson, NVNPI 1316904253

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.2% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,390, 6.3 times the $221 reported in 2019.

$4,220in general payments, 2019–2025

Across 174 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$975
  • GSK$799
  • Optinose US, Inc.$619
  • Inspire Medical Systems, Inc.$529
  • Sanofi$401
  • Pulse Biosciences, Inc.$229
  • plus $667 from 14 others

What the payments were for

  • Food & beverage$4,18499%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,220 in reported general payments places this provider in the 70th percentile of 41 otolaryngology providers in Nevada.

See all otolaryngology providers in Nevada

Medicare billing

Part B allowed, 2024
$158,881
Medicare patients
538
Services billed
1,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab19$77,468
Dupixent SyringeDupilumab14$53,692
Ipratropium Bromide352$10,046
Fluticasone Propionate212$2,555
Azelastine Hcl95$2,073
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav73$811
Methylprednisolone95$494
Omeprazole36$488
Levothyroxine Sodium55$370
Mupirocin57$343
Amitriptyline Hcl41$322
Nystatin16$322
Cephalexin34$285
Ciprofloxacin Hcl38$281
Ofloxacin11$266

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →